Discover 3,592 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,592
A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors
for
Solid Tumors
Location: Duarte CA, Santa Monica CA, West Valley City UT,
Sponsor: Adcentrx Therapeutics
Sex: All
Age: 18+
Code: NCT06710379
Phase 1, Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
for
Solid Tumor, Adult, Metastatic Breast Cancer,
Location: Duarte CA, Los Angeles CA, San Diego CA, Seattle WA,
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Duarte CA, Alhambra CA, Pasadena CA, Marina del Rey CA,
Sponsor: Jonsson Comprehensive Cancer Center
Sex: Female
Age: 0+
Code: NCT05595499
Phase 2, Recruiting
FEAST Perinatal Support Program Intervention
for
Diet, Healthy, Obesity, Cardiometabolic Syndrome
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Female
Age: 18+
Code: NCT06715787
Recruiting
A Pragmatic Trial of EAET for Veterans With Chronic Pain
for
Musculoskeletal Pain
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT07218757
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
for
Chronic Lymphocytic Leukemia (CLL),
Location: Duarte CA, Salt Lake City UT, Denver CO, Houston TX,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04830137
Phase 1, Recruiting
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
for
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
Location: Los Angeles CA, Portland OR, Oklahoma City OK,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT07094087
Phase 3, Recruiting
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Location: Duarte CA, Santa Monica CA, West Valley City UT,
Sponsor: Recursion Pharmaceuticals Inc.
Sex: All
Age: 12+
Code: NCT06678659
Phase 1, Phase 2, Recruiting
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
for
Chronic Graft-versus-host-disease
Location: Duarte CA, Palo Alto CA, Seattle WA, Atlanta GA,
Sponsor: Incyte Corporation
Sex: All
Age: 2 - 17
Code: NCT07124078
Phase 2, Recruiting
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center
for
Prediabetic State, PreDiabetes,
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18 - 70+
Code: NCT06897982
Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
for
Advanced Systemic Mastocytosis (AdvSM),
Location: Duarte CA, Los Angeles CA, Phoenix AZ, Stanford CA,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT04996875
Phase 2, Recruiting
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
for
Cancer, Fertility Preservation
Location: Duarte CA, La Jolla CA, San Diego CA
Sponsor: University of California, San Diego
Sex: All
Age: 0 - 50
Code: NCT05443737
Phase 3, Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndromes
Location: Duarte CA, Glendale CA, La Jolla CA, Henderson NV,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06499285
Phase 3, Recruiting
New
A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma